Thursday, April 25, 2024
Latest:
Pharmaceuticals

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Kari HagenLeave a Comment on Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Hyundai Bioscience announced on April 25th that its clinical development plan of oral “Niclosamide Metabolic Anticancer Drug” targeting cancer patients with intractable cancer caused by p53 gene […]

Read more
Health-Tech

Derm-Biome Pharmaceuticals’ topical therapy shows positive results in preclinical skin cancer trial: drug prevents the development of precancerous skin conditions and treats existing skin cancers with no observable side effects

Sigrun PedersenLeave a Comment on Derm-Biome Pharmaceuticals’ topical therapy shows positive results in preclinical skin cancer trial: drug prevents the development of precancerous skin conditions and treats existing skin cancers with no observable side effects
Health-Tech

Vitamyna, the Leading Eco-Conscious Supplement Company With a #1 Focus on Purity and Value, Launches Innovative Personalized Daily Vitamin Pack Builder, Designed for Individual Health Needs and Goals, With Monthly Doorstep Delivery

Kari HagenLeave a Comment on Vitamyna, the Leading Eco-Conscious Supplement Company With a #1 Focus on Purity and Value, Launches Innovative Personalized Daily Vitamin Pack Builder, Designed for Individual Health Needs and Goals, With Monthly Doorstep Delivery